I agree that this site is using cookies. You can find further informations here.
X
Tawbi, H.
35  results:
Articles (Online) X
Search for persons X
?
1

Phase 2 Study of aTezolizumab, bevAcizumab, and Cobinetinib..:

Burton, E. ; Honaker, V. ; Milton, D....
EJC Skin Cancer.  2 (2024)  - p. 100160 , 2024
Link: https://doi.org/10.1016/..
 
?
2

"Symptomatic" melanoma brain metastases: a call for clear d..:

Le Rhun, E. ; Weller, M. ; Anders, C....
European Journal of Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Efficacité et tolérance de l'association du nivolumab (NIVO..:

Tawbi, H. ; Forsyth, P. ; Hodi, F.S....
Annales de Dermatologie et de Vénéréologie.  146 (2019)  12 - p. A333-A334 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Advances in the systemic treatment of melanoma brain metast..:

Glitza Oliva, I.C. ; Schvartsman, G. ; Tawbi, H.
Annals of Oncology.  29 (2018)  7 - p. 1509-1520 , 2018
Link: https://doi.org/10.1093/..
 
?
5

A randomised phase II trial of selumetinib vs selumetinib p..:

Eroglu, Z ; Tawbi, H A ; Hu, J...
British Journal of Cancer.  112 (2015)  10 - p. 1644-1651 , 2015
Link: https://doi.org/10.1038/..
 
?
6

MC13-0078 PARP1 variants associated with response to Temozo..:

Sedgewick, A. ; Romkes, M. ; Buch, S....
European Journal of Cancer.  49 (2013)  - p. S33-S34 , 2013
Link: https://doi.org/10.1016/..
 
?
7

Author Correction: Distinct molecular and immune hallmarks ..:

Kim, Sang T. ; Chu, Yanshuo ; Misoi, Mercy...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
8

A phase 1 study of veliparib (ABT-888) plus weekly carbopla..:

Malhotra, Monica K. ; Pahuja, Shalu ; Kiesel, Brian F....
Breast Cancer Research and Treatment.  198 (2023)  3 - p. 487-498 , 2023
Link: https://doi.org/10.1007/..
 
?
9

A phase 1 and pharmacodynamic study of chronically-dosed, s..:

Manzo, Julia ; Puhalla, Shannon ; Pahuja, Shalu...
Cancer Chemotherapy and Pharmacology.  89 (2022)  5 - p. 721-735 , 2022
Link: https://doi.org/10.1007/..
 
?
10

Distinct molecular and immune hallmarks of inflammatory art..:

Kim, Sang T. ; Chu, Yanshuo ; Misoi, Mercy...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
11

Phase 1 study of safety, pharmacokinetics, and pharmacodyna..:

Maguire, William F. ; Schmitz, John C. ; Scemama, Jonas...
Cancer Chemotherapy and Pharmacology.  88 (2021)  4 - p. 643-654 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Dendritic cell vaccines targeting tumor blood vessel antige..:

Storkus, Walter J ; Maurer, Deena ; Lin, Yan...
Journal for ImmunoTherapy of Cancer.  9 (2021)  11 - p. e003675 , 2021
Link: https://doi.org/10.1136/..
 
?
13

The Great Debate at 'Immunotherapy Bridge', Naples, Decembe..:

Ascierto, Paolo A ; Bifulco, Carlo ; Galon, Jerome...
Journal for ImmunoTherapy of Cancer.  8 (2020)  2 - p. e000921 , 2020
Link: https://doi.org/10.1136/..
 
?
14

Defining tumor resistance to PD-1 pathway blockade: recomme..:

Kluger, Harriet M. ; Tawbi, Hussein A. ; Ascierto, Maria L....
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000398 , 2020
Link: https://doi.org/10.1136/..
 
?
15

B cells are associated with survival and immunotherapy resp..:

Petitprez, Florent ; de Reyniès, Aurélien ; Keung, Emily Z....
Nature.  577 (2020)  7791 - p. 556-560 , 2020
Link: https://doi.org/10.1038/..
 
1-15